Kyongbo Pharmaceutical Co., Ltd (KRX:214390)

Kyongbo Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 25, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	139,138	148,701	200,579	239,069	256,999	390,877
Market Cap Growth	-20.92%	-25.86%	-16.10%	-6.98%	-34.25%	97.94%
Enterprise Value	258,619	236,571	278,339	290,819	317,767	437,346
Last Close Price	5820.00	6220.00	8333.62	9873.46	10553.94	15976.08
PE Ratio	58.40	32.05	67.44	391.54	-	41.56
PS Ratio	0.55	0.62	0.93	1.22	1.51	1.82
PB Ratio	0.96	1.02	1.39	1.66	1.76	2.51
P/TBV Ratio	0.98	1.05	1.43	1.70	1.81	2.56
P/FCF Ratio	-	-	-	-	556.60	44.73
P/OCF Ratio	20.15	997.21	41.41	23.61	14.30	18.80
EV/Sales Ratio	1.03	0.99	1.29	1.48	1.86	2.03
EV/EBITDA Ratio	11.60	10.35	16.14	21.82	51.82	20.58
EV/EBIT Ratio	27.40	22.63	50.20	208.82	-	50.49
EV/FCF Ratio	-8.64	-	-	-	688.22	50.05
Debt / Equity Ratio	0.85	0.63	0.53	0.45	0.39	0.41
Debt / EBITDA Ratio	6.58	4.00	4.40	4.84	9.23	2.98
Debt / FCF Ratio	-	-	-	-	122.55	7.24
Asset Turnover	0.85	0.87	0.85	0.82	0.70	0.88
Inventory Turnover	1.78	1.94	2.40	2.65	2.27	2.63
Quick Ratio	0.39	0.44	0.53	0.61	0.59	0.79
Current Ratio	0.95	1.15	1.15	1.22	1.25	1.47
Return on Equity (ROE)	1.63%	3.19%	2.07%	0.42%	-4.97%	6.16%
Return on Assets (ROA)	1.25%	2.38%	1.37%	0.36%	-1.69%	2.21%
Return on Capital (ROIC)	1.48%	2.85%	1.62%	0.42%	-1.96%	2.55%
Return on Capital Employed (ROCE)	4.00%	6.90%	3.70%	1.00%	-4.50%	5.40%
Earnings Yield	1.70%	3.12%	1.48%	0.26%	-2.92%	2.41%
FCF Yield	-21.51%	-8.44%	-2.42%	-1.15%	0.18%	2.24%
Payout Ratio	50.51%	25.77%	40.19%	195.77%	-	25.42%
Buyback Yield / Dilution	0.48%	0.34%	-2.14%	1.62%	0.25%	-0.06%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.